In AMD experimental model systems, curcumin treatment resulted in the reduction of ROS, inhibition of apoptosis mediators and cellular inflammatory genes, and upregulation of the protective enzymes HO-1, thioredoxin, and NQO1 [186,187]. This evidence concerns the gene HMOX1 and age-related macular degeneration.